{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:19:45Z","timestamp":1768313985380,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3771-x","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T01:59:05Z","timestamp":1512179945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-9842","authenticated-orcid":false,"given":"Cavin E.","family":"Bekolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Soumah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousseni W.","family":"Tiemtore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdourahimi","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph-Desire","family":"Yuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Cisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,2]]},"reference":[{"key":"3771_CR1","volume-title":"Global AIDS Update 2016","author":"UNAIDS","year":"2016","unstructured":"UNAIDS. Global AIDS Update 2016. Geneva: Joint United Nations Programme on HIV\/AIDS; 2016."},{"issue":"14","key":"3771_CR2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","volume":"342","author":"K Antman","year":"2000","unstructured":"Antman K, Chang Y. Kaposi's Sarcoma. N Engl J Med. 2000;342(14):1027\u201338.","journal-title":"N Engl J Med"},{"key":"3771_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12885-016-2080-0","volume":"16","author":"E Freeman","year":"2016","unstructured":"Freeman E, Semeere A, Wenger M, Bwana M, Asirwa FC, Busakhala N, Oga E, Jedy-Agba E, Kwaghe V, Iregbu K, et al. Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi\u2019s sarcoma in five countries across sub-Saharan Africa. BMC Cancer. 2016;16:65.","journal-title":"BMC Cancer"},{"key":"3771_CR4","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.18.1.19929","volume":"18","author":"ME Herce","year":"2015","unstructured":"Herce ME, Kalanga N, Wroe EB, Keck JW, Chingoli F, Tengatenga L, Gopal S, Phiri A, Mailosi B, Bazile J, et al. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi. J Int AIDS Soc. 2015;18:19929.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"3771_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","volume":"16","author":"S Stewart","year":"1998","unstructured":"Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated liposomal doxorubicin study group. J Clin Oncol. 1998;16(2):683\u201391.","journal-title":"J Clin Oncol"},{"key":"3771_CR6","unstructured":"Guinea \ufeff HIV and AIDS estimates (2014) [\nhttp:\/\/www.unaids.org\/en\/regionscountries\/countries\/guinea\n\n]."},{"key":"3771_CR7","unstructured":"CNLS: Rapport National de la Riposte VIH\/SIDA 2014 [Progres 2010\u20132014] en Guinee. In. Conakry; 2015."},{"key":"3771_CR8","unstructured":"MSF: Out of Focus: How millions of people in West and Central Africa are being left out of the global HIV response. In. Brussels; 2016."},{"key":"3771_CR9","unstructured":"INS: Guinee: Enqu\u00eate D\u00e9mographique et de Sant\u00e9 et \u00e0 Indicateurs Multiples (EDS-MICS) 2012. In Conakry; 2013."},{"issue":"Supplement 1","key":"3771_CR10","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.annder.2013.01.415","volume":"140","author":"BF Dian\u00e9","year":"2013","unstructured":"Dian\u00e9 BF, Soumah MM, Tounkara TM, Keita M, Bald\u00e9 H, Camara AD, Doumbouya A, Kaba H, Ciss\u00e9 M. Profil \u00e9pid\u00e9mioclinique de la maladie de Kaposi \u00e9pid\u00e9mique en Guin\u00e9e \u00e0 travers une s\u00e9rie hospitali\u00e8re de 112 cas au service de dermatologie-MST du CHU Donka de Conakry. Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie. 2013;140(Supplement 1):S36\u20137.","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"issue":"12, Supplement","key":"3771_CR11","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1016\/j.annder.2014.09.297","volume":"141","author":"M Keita","year":"2014","unstructured":"Keita M, Koulibaly M, Soumah MM, Dian\u00e9 B, Tounkara TM, Camara AD, Bald\u00e9 H, Camara A, Ciss\u00e9 M. Morbidit\u00e9 et mortalit\u00e9 hospitali\u00e8res dans le service de dermatologie-MST du CHU de Conakry(Guin\u00e9e). Ann Dermatol Venereol. 2014;141(12, Supplement):S356\u20137.","journal-title":"Ann Dermatol Venereol"},{"issue":"14","key":"3771_CR12","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/QAD.0000000000000784","volume":"29","author":"D Leuenberger","year":"2015","unstructured":"Leuenberger D, Hebelamou J, Strahm S, De Rekeneire N, Balestre E, Wandeler G, Dabis F. Impact of the Ebola epidemic on general and HIV care in Macenta, Forest Guinea, 2014. AIDS (London, England). 2015;29(14):1883\u20137.","journal-title":"AIDS (London, England)"},{"issue":"9976","key":"3771_CR13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(15)60713-9","volume":"385","author":"JD Ndawinz","year":"2015","unstructured":"Ndawinz JD, Cisse M, Diallo MS, Sidibe CT, D'Ortenzio E. Prevention of HIV spread during the Ebola outbreak in Guinea. Lancet. 2015;385(9976):1393.","journal-title":"Lancet"},{"issue":"12, Supplement","key":"3771_CR14","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/j.annder.2014.09.490","volume":"141","author":"B Dian\u00e9","year":"2014","unstructured":"Dian\u00e9 B, Cond\u00e9 M, Soumah MM, Keita M, Tounkara TM, Camara AD, Bald\u00e9 H, Doumbouya A, Camara A, Ciss\u00e9 M. L\u2019\u00e9volution sous chimioth\u00e9rapie des patients atteints de maladie de Kaposi \u00e9pid\u00e9mique suivis au centre de traitement ambulatoire de l\u2019h\u00f4pital national Donka. Ann Dermatol Venereol. 2014;141(12, Supplement):S447.","journal-title":"Ann Dermatol Venereol"},{"issue":"9","key":"3771_CR15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","volume":"7","author":"SE Krown","year":"1989","unstructured":"Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group oncology committee. J Clin Oncol. 1989;7(9):1201\u20137.","journal-title":"J Clin Oncol"},{"key":"3771_CR16","unstructured":"Van Meerbeeck N, Moini\u00e9 S, Van Den Noortgate J: Medical Management of Kaposi Sarcoma and Safety measures for staff and patients during handling, preparation and administration of cytotoxic drugs: Bleomycin (B), vincristine (V) and Doxorubicine (D) 1st edn. Brussels: M\u00e9decins Sans Fronti\u00e8res 2010."},{"key":"3771_CR17","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1353-0","volume-title":"McCulloch CE: regression methods in biostatistics Boston","author":"EGD Vittinghoff","year":"2012","unstructured":"Vittinghoff EGD, Shiboski SC. McCulloch CE: regression methods in biostatistics Boston. MA: Springer US; 2012."},{"issue":"5","key":"3771_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/CCO.0b013e328349428d","volume":"23","author":"SE Krown","year":"2011","unstructured":"Krown SE. Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities. Curr Opin Oncol. 2011;23(5):463\u20138.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"3771_CR19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAI.0000000000000862","volume":"71","author":"E Amerson","year":"2016","unstructured":"Amerson E, Woodruff CM, Forrestel A, Wenger M, McCalmont T, LeBoit P, Maurer T, Laker-Oketta M, Muyindike W, Bwana M, et al. Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in East Africa. J Acquir Immune Defic Syndr. 2016;71(3):295\u2013301.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3771_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6600745","volume":"88","author":"M Dedicoat","year":"2003","unstructured":"Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer. 2003;88(1):1\u20133.","journal-title":"Br J Cancer"},{"issue":"2","key":"3771_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QCO.0b013e328335b01a","volume":"23","author":"A Mosam","year":"2010","unstructured":"Mosam A, Aboobaker J, Shaik F. Kaposi's sarcoma in sub-Saharan Africa: a current perspective. Curr Opin Infect Dis. 2010;23(2):119\u201323.","journal-title":"Curr Opin Infect Dis"},{"issue":"22","key":"3771_CR22","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1200\/JCO.2005.02.106","volume":"23","author":"P Bruzzi","year":"2005","unstructured":"Bruzzi P, Del Mastro L, Sormani MP, Bastholt L, Danova M, Focan C, Fountzilas G, Paul J, Rosso R, Venturini M. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients. J Clin Oncol. 2005;23(22):5117\u201325.","journal-title":"J Clin Oncol"},{"issue":"22","key":"3771_CR23","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1200\/JCO.2005.92.008","volume":"23","author":"TR Fleming","year":"2005","unstructured":"Fleming TR. Objective response rate as a surrogate end point: a commentary. J Clin Oncol. 2005;23(22):4845\u20136.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3771_CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","volume":"60","author":"A Mosam","year":"2012","unstructured":"Mosam A, Shaik F, Uldrick TS, Esterhuizen T, Friedland GH, Scadden DT, Aboobaker J, Coovadia HM. A randomized controlled trial of HAART versus HAART and chemotherapy in therapy-na\u00efve patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60(2):150\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"3771_CR25","volume":"11","author":"NK El-Mallawany","year":"2016","unstructured":"El-Mallawany NK, Kamiyango W, Slone JS, Villiera J, Kovarik CL, Cox CM, Dittmer DP, Ahmed S, Schutze GE, Scheurer ME, et al. Clinical factors associated with long-term complete remission versus poor response to chemotherapy in HIV-infected children and adolescents with Kaposi sarcoma receiving Bleomycin and vincristine: a retrospective observational study. PLoS One. 2016;11(4):e0153335.","journal-title":"PLoS One"},{"key":"3771_CR26","first-page":"CD003256","volume":"9","author":"CI Okwundu","year":"2014","unstructured":"Gbabe OF, Okwundu CI, Dedicoat M, Freeman EE. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database Syst Rev. 2014;9:CD003256.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T01:59:28Z","timestamp":1512179968000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3771-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3771"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3771-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"806"}}